Skip to main content
. Author manuscript; available in PMC: 2023 May 18.
Published in final edited form as: NEJM Evid. 2022 Jan 10;1(3):10.1056/evidoa2100057. doi: 10.1056/evidoa2100057

Figure 3.

Figure 3.

Covid-19 Death Rates by Vaccination Cohort and Age for the BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines for 14 U.S. Jurisdictions, from August 1 to September 4, 2021.

Covid-19 death rates are presented by vaccination cohort and age for the A) BNT162b2 (Pfizer–BioNTech), B) mRNA-1273 (Moderna), and C) Ad26.COV2.S (Janssen–Johnson & Johnson) vaccines. Only 14 jurisdictions contributed deaths. Wisconsin did not contribute death data due to lack of linkage between vital records and COVID-19 case surveillance. Error bars represent 95% confidence intervals. The widths of the intervals have not been adjusted for multiplicity and any of the inferences drawn may not be reproducible. Persons vaccinated with the Ad26.COV2.S vaccine in the January to February cohort and all persons 12 to 17 years of age vaccinated with either the mRNA-1273 or Ad26.COV2.S vaccine were excluded. *For a death count that is 15 or fewer, the rate may be unstable and should be interpreted with caution.